Shares of T2 Biosystems rise on federal contract for diagnostic tests

Lexington diagnostics maker T2 Biosystems is pairing up with the U.S. government to develop tests that could identify biological threats like anthrax — a deal that could alleviate some of the struggling device company’s financial concerns.